- Our Technology
Engineered for fragile biologics. Verified in viable skin
ExoGenis provides the delivery unlock for complex biologics, ensuring they reach the viable skin layer without degradation. Our platform is engineered for enabling predictable, repeatable placement, bypassing the limitations of topical creams and traditional injections.
Injection-free micro-channel formation
Depth-controlled placement
Preserved biologic integrity
Repeatable release kinetics
Exosome delivery validated on bench; pilot manufacturing underway.
- How It Works
Dissolvable microneedles explained
Phase 1 — Penetration Layer
Creates controlled micro-channels and ensures consistent insertion depth across skin types.
Phase 2 — payload Layer
Deposits fragile biologics at target depth and dissolves without leaving retained sharps
.svg)
Depth-controlled placement
Designed for unstable, dose-sensitive biologics that fail topically.
Predictable clinical performance
Engineered for repeatable outcomes across patients.
Preserved biologic activity
Fragile biologics remain stable during coating and delivery.
Structured biologic layering
Separation of penetration and payload improves control and stability.
No retained sharps
Dissolves after application - no disposal risk, no medical waste.
- Platform roadmap
One platform. Multiple biologics. Multiple indications.
ExoGenis is built around a biologic-compatible, dissolvable microneedle patch that serves as a configurable delivery platform.
The same patch architecture can be paired with different biologic payloads, indications, and clinical use cases without redesigning the delivery system.
current focus
Exosomes
Delivery of extracellular vesicles for regenerative and maintenance skin applications, where topical penetration is insufficient and injections are unsuitable for frequent use.
IN development
Growth factors
Precise placement of growth factors for tissue regeneration and repair.
IN development
Peptides
Targeted delivery of bioactive peptides that are unstable or ineffective when applied topically.
research phase
Vaccines (Future)
Exploration of intradermal delivery for immunologic applications, enabled by precise, minimally invasive placement.
future focus
Complex proteins
Delivery of larger biologic molecules that cannot penetrate the skin barrier through conventional formulations.
future focus
Combination therapies
Layered or sequential delivery of multiple biologics using the same microneedle platform.
- Platform positioning
We build delivery infrastructure, not cosmetic SKUs.
Interested in partnering with us?
We collaborate with aesthetic manufacturers and pharmaceutical labs to integrate our delivery system with your active ingredients.